Delivery Order SPE2DB25D3404-SPE2DB25FUQLT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lisdexamfetamine 70 mg capsules (100-count) with a ceiling value of $1,474.24. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lisdexamfetamine 10 mg capsules (90-count units) with a ceiling value of $1,132.24. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. The award represents a routine pharmaceutical procurement under the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) with a ceiling value of $20,729.23. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Lisdexamfetamine 40 mg capsules (90-count units) with a contract ceiling value of $1,339.45. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The place of performance is located at the contractor's corporate office in Conshohocken, PA, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) with a ceiling value of $1,629.94. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The product will be supplied from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of lisdexamfetamine 40 mg capsules (100-count units) with a ceiling value of $1,886.66. This firm fixed-price delivery order, with an ultimate completion date of May 21, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100 count) with a ceiling value of $2,031.40. This is a firm fixed-price delivery order with no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully in open federal procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $2,444.97 to AmerisourceBergen Drug Corp for Lisdexamfetamine 60 mg capsules (100-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) valued at $5,911.41. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Lisdexamfetamine 50 mg capsules (90-count units) valued at $1,057.44. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. The delivery order is due for completion by September 15, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUQLTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count) with a ceiling value of $1,246.23. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, and an ultimate completion date of September 18, 2025. The award represents a standard pharmaceutical supply transaction executed through the company's established vendor relationship with the federal government. This delivery order is executed under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion prime vendor agreement valued through December 2026 that authorizes the company to supply a wide range of pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical supplier for the Defense Health Agency and other federal healthcare systems, with an extensive portfolio of contractual arrangements demonstrating capability to fulfill diverse medical supply requirements across multiple therapeutic domains through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/17/25 |